Wren Laboratories – a Yale University spinoff and a CLIA, CAP, and NYSDOH-licensed laboratory – is dedicated to advancing precision medicine through cutting-edge mRNA diagnostics. Our mission is to revolutionize cancer diagnostics with innovative liquid biopsy mRNA technology, improving patient care and accelerating drug development.
We are pioneering the field with machine learning-based liquid biopsy mRNA expression tests, designed for both standard-of-care applications and pharmaceutical trials. In addition to our regulated assays—NETest® and PROSTest® for neuroendocrine and prostate cancers—our pipeline includes targeted solutions for colorectal, lung, breast, pancreatic, melanoma, and multiple myeloma cancers. We also offer customized gene signature assays tailored to specific research needs.
Our services span the entire drug development paradigm, from discovery to patient stratification and companion diagnostic development, supporting precision oncology at every stage. Our proprietary blood collection tube keeps RNA stable for at least 10 days at ambient temperature and it significantly outperformed EDTA, PaxGene and Streck tubes.
www.wren-laboratories.com
